Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous

Louise Y Sun1,2,3, Mario Gaudino4, Robert J Chen1

  • 1Division of Cardiac Anesthesiology, Department of Anesthesiology and Pain Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

JAMA Cardiology
|April 9, 2020
PubMed

Insights

Percutaneous coronary intervention (PCI) is linked to higher mortality and major adverse cardiovascular events (MACE) compared to coronary artery bypass grafting (CABG) in patients with severely reduced left ventricular ejection fraction (LVEF). These findings aid clinical decision-making for high-risk cardiac patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Severely reduced left ventricular ejection fraction (LVEF < 35%) poses significant risks for patients with complex coronary artery disease.
  • Limited data exists comparing long-term outcomes of revascularization strategies (PCI vs. CABG) in this vulnerable patient population.

Purpose of the Study:

  • To compare the long-term efficacy and safety of percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) in patients with severely reduced LVEF.

Main Methods:

  • Retrospective cohort study in Ontario, Canada (2008-2016) including 2,397 propensity-matched patients (PCI vs. CABG) with LVEF < 35% and complex coronary artery disease.
  • Primary outcome: all-cause mortality. Secondary outcomes: cardiovascular death, major adverse cardiovascular events (MACE), and individual MACE components.

Main Results:

  • Patients undergoing PCI experienced significantly higher rates of all-cause mortality (HR 1.6), cardiovascular death (HR 1.4), and MACE (HR 2.0) compared to CABG.
  • PCI was also associated with increased rates of subsequent revascularization, myocardial infarction hospitalization, and heart failure hospitalization.

Conclusions:

  • Percutaneous coronary intervention (PCI) is associated with worse long-term outcomes, including higher mortality and major adverse cardiovascular events (MACE), compared to coronary artery bypass grafting (CABG) in patients with severely reduced left ventricular ejection fraction.
  • These findings suggest that CABG may be a preferred revascularization strategy for selected patients with severely impaired LVEF and complex coronary artery disease.
Abstract